New hope for tough liver cancers: immunotherapy plus targeted chemo
NCT ID NCT06904170
First seen Nov 17, 2025 · Last updated May 12, 2026 · Updated 27 times
Summary
This study tests whether adding a liver-directed chemotherapy (GEMOX) to standard immunotherapy (durvalumab + tremelimumab) works better than immunotherapy alone for people with advanced liver cancer that has a high tumor burden. About 196 adults with liver cancer that has spread into major blood vessels or covers more than half the liver will take part. The goal is to see if the combination shrinks tumors and helps people live longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AP-HP Hôpital Beaujon
RECRUITINGClichy, 92110, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
AP-HP Hôpital Cochin
RECRUITINGParis, 75014, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHRU de Strasbourg
NOT_YET_RECRUITINGStrasbourg, 67091, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Hôtel-Dieu
NOT_YET_RECRUITINGNantes, 44093, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Bordeaux
NOT_YET_RECRUITINGBordeaux, 33604, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Montpellier
NOT_YET_RECRUITINGMontpellier, 34295, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Poitiers
NOT_YET_RECRUITINGPoitiers, 86000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Rangueil
RECRUITINGToulouse, 31400, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Eugene Marquis
RECRUITINGRennes, 35042, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Georges Francois Leclerc
NOT_YET_RECRUITINGDijon, 21079, France
Contact
Contact Phone: •••-•••-••••
-
Hôpital Saint Joseph
RECRUITINGMarseille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.